Asarfi Hospital Surges on Q3 Earnings, Expansion Plans Offset Occupancy Drop

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
Asarfi Hospital Surges on Q3 Earnings, Expansion Plans Offset Occupancy Drop
Overview

Asarfi Hospital Limited reported a robust Q3 FY26, with revenue soaring 40% YoY to ₹4,606 Lakhs and PAT doubling (+102%) to ₹548 Lakhs. The hospital is strategically investing in advanced medical technology and expanding its Cancer Hospital capacity. However, a significant 43 percentage point drop in occupancy for the Cancer Hospital unit from 80% to 37% YoY presents a notable concern amidst strong overall performance.

📉 The Financial Deep Dive

Asarfi Hospital Limited has posted a strong financial performance for the quarter ended December 31, 2025 (Q3 FY26), showcasing significant year-over-year (YoY) growth across key metrics.

The Numbers:

  • Revenue surged by 40% YoY to ₹4,606 Lakhs (₹46.06 Cr) from ₹3,289 Lakhs in Q3 FY25.
  • EBITDA grew by 45% YoY to ₹1,012 Lakhs (₹10.12 Cr), with EBITDA margins expanding slightly to 22% from 21% YoY.
  • EBIT demonstrated robust operational efficiency, surging 81% YoY to ₹876 Lakhs, reflecting an improved EBIT margin of 19% compared to 15% in the prior year.
  • Profit After Tax (PAT) more than doubled, showing a 102% YoY growth to ₹548 Lakhs (₹5.48 Cr) from ₹272 Lakhs, with PAT margins strengthening to 12% from 8% YoY.
  • For the nine-month period (9M FY26), consolidated revenue grew 46% YoY to ₹12,667 Lakhs (₹126.67 Cr), and consolidated PAT increased by 82% YoY to ₹1,274 Lakhs (₹12.74 Cr).

The Quality:
The company's operational efficiency is clearly visible through the expanding EBIT and PAT margins. The Super-Specialty Hospital unit reported an Average Revenue Per Operating Bed (ARPOB) of ₹24,293. However, a key point of concern is the occupancy rate for the Cancer Hospital unit, which decreased sharply to 37% in Q3 FY26 from a substantial 80% in Q3 FY25. This represents a significant drop of 43 percentage points YoY. In contrast, the Super-Specialty unit maintained a healthy 61% occupancy rate.

The Grill (Management Strategy & Outlook):
Despite the occupancy challenge in its Cancer Hospital, Asarfi Hospital is aggressively pursuing growth. Strategic investments are being made in advanced medical technology, including a GE Healthcare Dual-Detector SPECT Gamma Camera and a Philips Azurion 5 M12 Image-Guided Therapy System, with completion expected by March 2026. These upgrades aim to enhance diagnostic and interventional services.

The growth strategy for the cancer hospital involves expanding bed capacity, establishing a Bone Marrow Transplant Unit, and exploring Operations & Maintenance (O&M) contracts. A landmark development is the MoU with Gleneagles Hospital, Chennai, to set up Jharkhand’s first Multi-Organ Transplant Unit. The company aspires to be a leading healthcare provider in Eastern India.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.